People
Centers & Teams
Centers & Teams
Find information about our Centers and Teams.
All
Behavioral health
Cardiovascular health
Center for Evaluation and Survey Research
Critical Care Research Center
Diabetes
International Diabetes Center
Orthopedic trauma
Primary care, pediatrics
Research Methodology Group
TRIA Research and Education Center
Worksite and occupational health
Cancer Research Center
Center for Chronic Care Innovation
Community and population health
Dental and oral health
Health economics
Neuroscience Research Centers
Pregnancy and child health
Pulmonology
Rheumatology
Vaccines
Knowledge
About
About
FAQ
HealthPartners Institute
People
Centers & Teams
Knowledge
About
HealthPartners Institute
J. Vansteenkiste
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
.
Lancet Oncology.
2018
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
.
New England Journal of Medicine.
2018
Contact
full name
J.
Vansteenkiste
Quick Info
Collaboration
Co-author network
Map of science
Picked up by
13
news outlets
Referenced in
1
policy sources
Posted by
57
X users
On
4
Facebook pages
Reddited by
1
401
readers on Mendeley
1
readers on CiteULike
See more details
Picked up by
51
news outlets
Blogged by
5
Referenced in
3
policy sources
Posted by
272
X users
Referenced in
2
patents
Mentioned by
1
peer review sites
On
3
Facebook pages
Mentioned in
1
Google+ posts
Reddited by
2
Highlighted by
1
platforms
On
1
videos
Referenced in
9
clinical guideline sources
1305
readers on Mendeley
See more details